Herbal therapy to prevent infection after stem cell transplant
Treatments studied
Part of Blood & lymphatic, Digestive system clinical trials.
This trial tests whether a special herbal treatment applied to the skin can help prevent infections around the bottom that are caused by diarrhea after a stem cell transplant. It may be an option for people who are getting a transplant for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be getting a stem cell transplant from a donor (allogeneic) for the first time.
- You must be between 14 and 70 years old.
- You must have a blood cancer or aplastic anemia.
- You must not have had an active intestinal infection in the last 2 weeks.
- You must not have inflammatory bowel disease or irritable bowel syndrome.
- You must be in good enough health to tolerate the transplant and the herbal treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of donor immune cell (depleted of CD45RA cells) to see if it can prevent serious viral infections in people at high risk after a stem cell transplant from a half-matched donor.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help your immune system recover better after a stem cell transplant. It is for people whose immune markers are still low 6 months after transplant.
This trial tests whether giving medication after a donor stem cell transplant can prevent the return of very high-risk myelodysplastic syndrome (MDS). It is for people who have a suitable donor and are healthy enough for the procedure.
This Phase 2 study tests an oral “fecal microbiotherapy” treatment given before and around an allogeneic (donor) stem-cell transplant to help prevent transplant-related complications. It may help by improving gut and immune function during the high-risk transplant period.
This trial tests whether a special probiotic made from the patient's own gut bacteria and their donor's can help fix gut problems caused by a complication called graft-versus-host disease (aGVHD) after a stem cell transplant. It might help patients who are over 50 and scheduled for a specific type of transplant.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.